Team:Trieste/parts/9
From 2012.igem.org
(Difference between revisions)
Line 13: | Line 13: | ||
<p> LL-37 is a 37-residue, amphipathic, helical peptide found throughout the body and has been shown to exhibit a broad spectrum of antimicrobial activity. </br> | <p> LL-37 is a 37-residue, amphipathic, helical peptide found throughout the body and has been shown to exhibit a broad spectrum of antimicrobial activity. </br> | ||
<center><img src="https://static.igem.org/mediawiki/2012/c/cd/Ll37_structure.png" width="350px"/></br> | <center><img src="https://static.igem.org/mediawiki/2012/c/cd/Ll37_structure.png" width="350px"/></br> | ||
- | The figure show an electrostatic surface plot and a cartoon representation of LL-37, stressing the amphipathic nature of the peptide. | + | The figure show an electrostatic surface plot and a cartoon representation of LL-37, stressing the amphipathic nature of the peptide. </center> </br> |
- | </center></br> | + | |
</br> | </br> | ||
The antimicrobial peptides (AMPs) are present in all species investigated. They form an important part of innate immunity, protecting the organism from infection by directly killing invading bacteria. Since pathogenic microorganism show an increasing tendency to be immune against common antibiotics, AMPs carry remarkable pharmaceutical promise as next-generation antibiotics. </br> | The antimicrobial peptides (AMPs) are present in all species investigated. They form an important part of innate immunity, protecting the organism from infection by directly killing invading bacteria. Since pathogenic microorganism show an increasing tendency to be immune against common antibiotics, AMPs carry remarkable pharmaceutical promise as next-generation antibiotics. </br> | ||
</br> | </br> | ||
- | <center><img src="https://static.igem.org/mediawiki/2012/0/06/Ll_37_mic.png" width="350px"/></br> | + | <center><img src="https://static.igem.org/mediawiki/2012/0/06/Ll_37_mic.png" width="350px"/></br></center> |
</br> | </br> | ||
The electron micrographs below show how a bacterium is affected by LL-37, a human antimicrobial peptide. The bacterium dies if a threshold called 'minimum inhibitory concentration' (MIC) is reached. Even at concentrations below the MIC, the bacterium shows visible damage.</br> | The electron micrographs below show how a bacterium is affected by LL-37, a human antimicrobial peptide. The bacterium dies if a threshold called 'minimum inhibitory concentration' (MIC) is reached. Even at concentrations below the MIC, the bacterium shows visible damage.</br> |
Revision as of 12:47, 24 September 2012
BBa_K875009
More
Description
LL-37 is a 37-residue, amphipathic, helical peptide found throughout the body and has been shown to exhibit a broad spectrum of antimicrobial activity.